Tetra Bio-Pharma’s Management Post Financing Corporate Update
Tetra Bio-Pharma Inc. is pleased to provide investors with an update on our research, regulatory and commercial activities after closing the public placement.
Tetra Bio-Pharma Inc. is pleased to provide investors with an update on our research, regulatory and commercial activities after closing the public placement.
Tetra Bio-Pharma Inc. is pleased to announce it has closed its previously announced short form prospectus offering of units of the Corporation, including the exercise in full of the Agents' over-allotment option.
Tetra Bio-Pharma Inc. is pleased to announce that its wholly owned subsidiary Panag Pharma Inc. has received a repayable Government of Canada contribution of $500,000 through the Atlantic Canada Opportunities Agency’s (ACOA) Business Development Program.
Tetra Bio-Pharma Inc. wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity.